Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dyskinesia, Drug-Induced”

83 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 83 results

Post-approval studies (Phase 4)Study completedNCT03698331
What this trial is testing

The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine

Who this might be right for
Tardive Dyskinesia (TD)
Neurocrine Biosciences 89
Testing effectiveness (Phase 2)Study completedNCT01921270
What this trial is testing

Dysport for the Treatment of OMD

Who this might be right for
Oral DystoniaTardive Dystonia
Emory University 18
Early research (Phase 1)WithdrawnNCT05053321
What this trial is testing

Reduction of Demoralization in Patients With Tardive Dyskinesia After Treatment With Valbenazine

Who this might be right for
Tardive Dyskinesia
Yale University
Testing effectiveness (Phase 2)Study completedNCT02500628
What this trial is testing

Heart Rate Variability in Response to Metformin Challenge

Who this might be right for
FibromyalgiaMitochondrial DiseasesMovement Disorders+1 more
Woodinville Psychiatric Associates 61
Large-scale testing (Phase 3)WithdrawnNCT03254186
What this trial is testing

Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Emory University
Post-approval studies (Phase 4)Not Yet RecruitingNCT06997198
What this trial is testing

Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities

Who this might be right for
Tardive DyskinesiaIntellectual DisabilityDevelopmental Disabilities
University Hospitals Cleveland Medical Center 25
Post-approval studies (Phase 4)Study completedNCT00114595
What this trial is testing

Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia

Who this might be right for
DyskinesiaSchizophrenia
University of Stellenbosch 84
Not applicableStudy completedNCT01429207
What this trial is testing

Capturing Parkinson's Disease Medication Side Effects During Daily Activities

Who this might be right for
Parkinson's DiseaseDyskinesia
Great Lakes NeuroTechnologies Inc. 15
Testing effectiveness (Phase 2)Ended earlyNCT00693472
What this trial is testing

Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145)

Who this might be right for
Akathisia, Drug-InducedAntipsychotic AgentsMovement Disorders
Merck Sharp & Dohme LLC 46
Testing effectiveness (Phase 2)WithdrawnNCT02064010
What this trial is testing

Trial Evaluating SNC-102 in Drug-Induced Tardive Dyskinesia

Who this might be right for
Drug-induced Tardive Dyskinesia
Synchroneuron Inc.
Testing effectiveness (Phase 2)Study completedNCT01733121
What this trial is testing

NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 102
Large-scale testing (Phase 3)WithdrawnNCT01908452
What this trial is testing

Pyridoxal Kinase Activity in Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Beersheva Mental Health Center
Large-scale testing (Phase 3)Study completedNCT02405091
What this trial is testing

Safety and Tolerability Study of NBI-98854 for the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 167
Very early researchStudy completedNCT04794413
What this trial is testing

Pimavanserin Treatment in TS

Who this might be right for
Tourette SyndromeTardive Dyskinesia
Joseph Jankovic 10
Not applicableActive Not RecruitingNCT02252380
What this trial is testing

ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders

Who this might be right for
Movement DisordersEssential TremorHolmes Tremor+6 more
InSightec 10
Testing effectiveness (Phase 2)UnknownNCT04147949
What this trial is testing

AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia

Who this might be right for
Parkinson DiseaseDyskinesia, Medication-InducedL-Dopa Causing Adverse Effects in Therapeutic Use
VistaGen Therapeutics, Inc. 20
Not applicableStudy completedNCT01467089
What this trial is testing

The Assessment of Movement Disorders Utilizing Live Two-Way Video

Who this might be right for
Tardive Dyskinesia
Northwell Health 37
Testing effectiveness (Phase 2)Ended earlyNCT01789047
What this trial is testing

Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's DiseaseDrug Induced Dyskinesia
Rush University Medical Center 42
Not applicableStudy completedNCT03287778
What this trial is testing

Randomized Controlled Trial of Pyridoxine for Tardive Dyskinesia

Who this might be right for
Tardive DyskinesiaAntipsychotic Agents
University of North Carolina, Chapel Hill 17
Not applicableLooking for participantsNCT06570824
What this trial is testing

RTMS as an Intervention for Levodopa-induced Dyskinesia

Who this might be right for
Dyskinesia, Drug-InducedParkinson Disease
Danish Research Centre for Magnetic Resonance 68
Load More Results